Generating a CRISPR knockout cell line is one thing. Proving that the loss of that gene does something biologically relevant is another.
For researchers studying ADA2 (CECR1) , the true value of a knockout model lies in its functional phenotype—specifically, how the absence of ADA2 alters immune signaling. Previous studies have established that ADA2 plays a critical role in monocyte-to-macrophage differentiation and the regulation of inflammatory responses .
But what does that actually look like in a dish? AhelixBio has taken the guesswork out of validation. Below, we walk through the key functional assays performed on our ADA2 KO THP-1 Line to confirm it mirrors the human disease state of DADA2 (Deficiency of ADA2) .
One of the hallmark features of ADA2 deficiency is the skewing of macrophages away from the anti-inflammatory M2 state and toward a destructive M1 (pro-inflammatory) state. This drives the vasculitis and tissue damage seen in DADA2 patients .
The AhelixBio Experiment:
Model: Wild Type (WT) THP-1 vs. ADA2 KO THP-1
Protocol: Cells were differentiated into macrophages using PMA, then stimulated with LPS + IFNy (M1 conditions) or IL-4/IL-13 (M2 conditions).
Readout: ELISA for TNF-alpha and IL-10; Flow cytometry for CD86 (M1 marker) vs. CD163 (M2 marker).
The Result:
Unlike WT controls, the ADA2 KO macrophages displayed a significantly elevated TNF-alpha secretion under basal conditions. Furthermore, they demonstrated a reduced capacity to upregulate the M2 marker CD163. This confirms that loss of ADA2 intrinsically locks THP-1 derived macrophages into a "hyper-inflammatory" phenotype, faithfully recapitulating DADA2 patient data
DADA2 Drug Screening: Use the hyper-inflammatory phenotype (high TNF-alpha) to test biologics or JAK inhibitors for efficacy in calming the immune response.
Macrophage Biology: Study the genetic switches that control M1 vs. M2 fate decisions. The ADA2 KO line is a stable "pro-inflammatory" background to test polarization agents.
Adenosine Signaling: Dissect the enzymatic vs. non-enzymatic functions of ADA2 by supplementing the media with ADA2 enzyme or pathway inhibitors.
The AhelixBio ADA2 Knockout THP-1 Cell Line is more than a genomic edit—it is a validated disease model. Whether you are recapitulating the vasculitis of DADA2 or looking for the switch that controls macrophage inflammation, this line offers a reproducible, ready-to-use solution.
Order the validated ADA2 KO THP-1 Cell Line today and trust your data.
Q: Does ADA2 deficiency affect macrophage differentiation in THP-1 cells?
Q: How do ADA2 knockout cells respond to TLR stimulation?
A: ADA2 knockdown or knockout models show altered cytokine secretion profiles upon TLR stimulation, generally producing higher levels of inflammatory cytokines like TNF-alpha and IL-6 compared to wild-type cells